Richard Wooster

Richard Wooster

No open positions remaining
61 year
Health Technology
Consumer Services

Profile

Richard Wooster is an Independent Director at Ikena Oncology, Inc. and a Director at Illuminating Drug Discovery Ltd. He previously served as the Chief Scientific Officer at Translate Bio, Inc. from 2019 to 2021.
Prior to that, he was a Senior Investigator at Wellcome Trust Sanger Institute.
Richard also held the position of Vice President & Unit Head-Oncology at GlaxoSmithKline LLC from 2006 to 2013.
From 2013 to 2019, he served as the Chief Scientific Officer & President-R&D at Tarveda Therapeutics, Inc. Dr. Wooster obtained his undergraduate and doctorate degrees from the University Of Dundee.

Richard Wooster active positions

CompaniesPositionStart

Former positions of Richard Wooster

CompaniesPositionEnd
TRANSLATE BIO, INC. Chief Tech/Sci/R&D Officer 14/09/2021
President 01/03/2015
Corporate Officer/Principal 01/01/2013
IMAGENEBIO, INC. Director/Board Member -
Corporate Officer/Principal -
See the detail of Richard Wooster's experience

Training of Richard Wooster

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Wooster
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!